BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22157857)

  • 1. NIA commentary: translational issues in Alzheimer's disease drug development.
    Buckholtz NS; Ryan LM; Petanceska S; Refolo LM
    Neuropsychopharmacology; 2012 Jan; 37(1):284-6. PubMed ID: 22157857
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.
    Petanceska S; Ryan L; Silverberg N; Buckholtz N
    Alzheimers Dement; 2009 Mar; 5(2):130-2. PubMed ID: 19328442
    [No Abstract]   [Full Text] [Related]  

  • 3. NIA funding for Alzheimer's research.
    Barr RA
    Lancet Neurol; 2011 Aug; 10(8):683. PubMed ID: 21777823
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease".
    Korczyn AD
    Alzheimers Dement; 2011 May; 7(3):333-4. PubMed ID: 21575875
    [No Abstract]   [Full Text] [Related]  

  • 5. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.
    Khachaturian AS; Hayden KM; Mielke MM; Tang Y; Lutz MW; Gustafson DR; Kukull WA; Mohs R; Khachaturian ZS
    Alzheimers Dement; 2018 Apr; 14(4):532-534. PubMed ID: 29653605
    [No Abstract]   [Full Text] [Related]  

  • 6. NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease.
    Silverberg N; Elliott C; Ryan L; Masliah E; Hodes R
    Alzheimers Dement; 2018 Apr; 14(4):576-578. PubMed ID: 29653608
    [No Abstract]   [Full Text] [Related]  

  • 7. US Alzheimer's disease researchers feel the pinch.
    Williams R
    Lancet Neurol; 2011 May; 10(5):408-9. PubMed ID: 21511195
    [No Abstract]   [Full Text] [Related]  

  • 8. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria.
    Carrillo MC; Dean RA; Nicolas F; Miller DS; Berman R; Khachaturian Z; Bain LJ; Schindler R; Knopman D;
    Alzheimers Dement; 2013 Sep; 9(5):594-601. PubMed ID: 24007744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the research field of neuropharmacology in China.
    Li J
    Cell Mol Neurobiol; 2008 Feb; 28(2):185-204. PubMed ID: 18240016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Alzheimer's gamble.
    Kaiser J
    Science; 2018 Aug; 361(6405):838-841. PubMed ID: 30166471
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevent Alzheimer's disease by 2020: a national strategic goal.
    Khachaturian ZS; Khachaturian AS
    Alzheimers Dement; 2009 Mar; 5(2):81-4. PubMed ID: 19328433
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease.
    Visser PJ; Vos S; van Rossum I; Scheltens P
    Alzheimers Dement; 2012 Nov; 8(6):560-3. PubMed ID: 23102126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systems-based model of Alzheimer's disease.
    Tang Y; Lutz MW; Xing Y
    Alzheimers Dement; 2019 Jan; 15(1):168-171. PubMed ID: 30102884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging.
    Petersen RC
    Alzheimers Dement; 2009 Mar; 5(2):105-7. PubMed ID: 19328436
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alzheimer's Disease Cooperative Study (ADCS)].
    Mori H; Ikeuchi T
    Brain Nerve; 2014 Jun; 66(6):691-8. PubMed ID: 24899351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preface to the special issue "Novel pharmaconeurogenetic approaches arising from progress in translational genetics".
    Renger JJ; Kern JT
    J Neurogenet; 2011 Dec; 25(4):117-9. PubMed ID: 22074379
    [No Abstract]   [Full Text] [Related]  

  • 17. The National Institute on Aging and Alzheimer's Association research framework: A commentary from the Cochrane Dementia and Cognitive Improvement Group.
    McCleery J; Flicker L; Richard E; Quinn TJ
    Alzheimers Dement; 2019 Jan; 15(1):179-181. PubMed ID: 30642437
    [No Abstract]   [Full Text] [Related]  

  • 18. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.
    Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.
    Khachaturian ZS
    Alzheimers Dement; 2011 May; 7(3):253-6. PubMed ID: 21575869
    [No Abstract]   [Full Text] [Related]  

  • 20. The National Institute on Aging Centers on the demography and economics of aging and Alzheimer's disease and Alzheimer's related dementias: History, impact, and future challenges.
    Sonnega A; Mather M; Scommegna P
    J Am Geriatr Soc; 2024 May; 72(5):1598-1601. PubMed ID: 38445825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.